| General Information | |||
|---|---|---|---|
| Term | GM1 gangliosidosis | ID (Ontology) | DOID:3322 (Human Disease) |
| Definition | A gangliosidosis that is characterized by progressive destruction of nerve cells in the brain and spinal cord and that has_material_basis_in mutations in the gene encoding beta-galactosidase-1 (GLB1) resulting in build up of GM1 ganglioside. | ||
| Also Known As | "Beta-galactosidase deficiency" ; "deficiency of beta-galactosidase" ; "gangliosidosis GM1" | ||
| Comment | |||
| Links to External Ontologies | |||
| DO.org | |||
| Annotations | |||
| Records annotated with this term OR any of its CHILD TERMS | |||
Full annotation statements including this term (annotations to child terms are NOT included), and relevant FlyBase records
|
|||
|
No relevant statements available
|
|||
|
||||||
autosomal recessive disease__ sphingolipidosis_____________| gangliosidosis |__GM1 gangliosidosis 2 rec. |__GM1 gangliosidosis type 1 2 rec. |__GM1 gangliosidosis type 2 2 rec. |__GM1 gangliosidosis type 3 2 rec. |
| Spanning Tree View Settings | |||
|---|---|---|---|
| Parents/Children View Depth |
|||
Relationships
|
|||
| Is a | gangliosidosis | ||
| Part of | |||
Synonyms & Secondary IDs
|
|||
| Synonyms | |||
|
|||
| Secondary IDs | |||
|
|
|||
External Crossreferences & Linkouts
|
|||
|
GARD:10891 ICD10CM:E75.19 MESH:D016537 NCI:C84739 SNOMEDCT_US_2023_03_01:32917001 UMLS_CUI:C0085131 |
|||